AbbVie (NYSE:ABBV – Get Rating) was downgraded by investment analysts at Daiwa Capital Markets from an “outperform” rating to a “neutral” rating in a report released on Friday, The Fly reports. ABBV has been the subject of a number of other research reports. Wells Fargo & Company lifted their price objective on shares of AbbVie […]